TROAP and hepatocellular carcinoma: To explore the targeted therapeutic potential of DYRK1 in HCC cells with upregulated TROAP, AZ191 was used to treat the subcutaneous xenograft tumors derived from Hep3B or PLC8024 cells in nude mice.